Showing results (41-50 of 310) with videos related to
Sort By:
Pageof 31
Hormones (Athens, Greece)|July 11, 2016
Development and validation of an osteoporosis treatment questionnaire (OSTREQ) evaluating physicians' criteria in the choice of treatmentPolyzois Makras, Antonios Galanos, Stavroula Rizou, et al.International Journal of Molecular Sciences|April 26, 2020
Gender Predilection in Sporadic Parathyroid AdenomasMaria P Yavropoulou, Athanasios D Anastasilakis, Argyro Panagiotakou, et al.Frontiers of Hormone Research|August 26, 2015
Clinical Syndromes Related to Gastrointestinal Neuroendocrine NeoplasmsGeorgios Boutzios, Gregory KaltsasBest Practice & Research. Clinical Gastroenterology|April 16, 2013
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)George Kanakis, Gregory KaltsasJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2024
The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2025
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trialPolyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 21, 2020
Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be EnoughAthanasios D Anastasilakis, Georgios Trovas, Alexia Balanika, et al.Clinical Endocrinology|March 5, 2013
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosisPolyzois Makras, Stergios A Polyzos, Athanasios Papatheodorou, et al.Trends in Endocrinology and Metabolism: TEM|June 30, 2007
Endocrine manifestations in Langerhans cell histiocytosisPolyzois Makras, Krystallenia I Alexandraki, George P Chrousos, et al.Endocrine|November 30, 2011
Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapyKrystallenia I Alexandraki, Gregory KaltsasPageof 31